Tyropanoate sodium

CAS: 7246-21-1

Ref. 3D-HAA24621

Informação sobre produto

• Nome: Tyropanoate sodium
• Sinónimos: 2-(3-Butyramido-2,4,6-triiodbenzyl)buttersaeure, Natrium-Salz, 3-Butyramido-alpha-ethyl-2,4,6-triiodohydrocinnamic acid sodium salt, Benzenepropanoic acid, alpha-ethyl-2,4,6-triiodo-3-((1-oxobutyl)amino)-, monosodium salt, Benzenepropanoic acid, α-ethyl-2,4,6-triiodo-3-[(1-oxobutyl)amino]-, monosodium salt, Benzenepropanoic acid, α-ethyl-2,4,6-triiodo-3-[(1-oxobutyl)amino]-, sodium salt (1:1), Bilopac, Bilopaque, Hydrocinnamic acid, 3-butyramido-alpha-ethyl-2,4,6-triiodo-, monosodium salt (8CI), Hydrocinnamic acid, 3-butyramido-alpha-ethyl-2,4,6-triiodo-, sodium salt, Hydrocinnamic acid, 3-butyramido-α-ethyl-2,4,6-triiodo-, monosodium salt, Hydrocinnamic acid, 3-butyramido-α-ethyl-2,4,6-triiodo-, sodium salt, Lumopaque, Natrii tyropanoas, Natrii tyropanoas [INN-Latin], Natrium 2-(3-butyramido-2,4,6-triiodbenzyl)butyrat, Natrium tyropanoat, Nsc-107434, Sodium 2-[3-(Butanoylamino)-2,4,6-Triiodobenzyl]Butanoate, Sodium 3-butyramido-alpha-ethyl-2,4,6-triiodohydrocinnamate, Sodium 3-butyramido-α-ethyl-2,4,6-triiodohydrocinnamate, Tiropanoato sodico, Tiropanoato sodico [INN-Spanish], Tyropanoate, Tyropanoate Sodium [USAN], Tyropanoate de sodium, Tyropanoate de sodium [INN-French], Tyropanoic acid sodium salt, Tyropaque, Unii-Xrj0P5Fayo, Win 8851-2, alpha-Ethyl-beta-(2,4,6-triiodo-3-butyramidophenyl)propionic acid sodium salt, α-Ethyl-β-(2,4,6-triiodo-3-butyramidophenyl)propionic acid sodium salt

Descrição

Tyropanoate sodium is a radiocontrast agent that is used to produce images in diagnostic procedures. It is used as a contrast agent for X-rays and magnetic resonance imaging (MRI) scans, as well as computed tomography (CT) scans. Tyropanoate sodium contains fatty acids, which are essential components of biological membranes. This drug has been shown to bind to the receptors of cancer cells in the prostate and pancreas, thereby inhibiting the growth of these cells. Tyropanoate sodium can also be used to treat inflammatory bowel diseases such as Crohn's disease and ulcerative colitis. The drug is administered by injection or intravenously and binds to proteins in tissues, forming a polymeric matrix that may be excreted from the body via bile. Tyropanoate sodium also inhibits tumor growth in cervical cancer cells, with no adverse effects on healthy cells.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 663 g/mol
• Fórmula: C₁₅H₁₇I₃NNaO₃
• Pureza: Min. 95%